Thank you! Your submission has been received!
It looks like that email is already in our system - thanks for signing up!
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
×
back to portfolio︁

3D printing of synthetic human tissues to advance drug discovery and development.

Prellis is a pioneer in the construction of human cells, organoids and organoid systems based on proprietary biologics workflows. Prellis has developed the EXIS antibody discovery platform which can be used to generate antibody libraries with novel, target-specific drug candidates. The EXIS platform mimics the natural human immune process in vitro, representing the gold standard in drug discovery.

CEO
Mike Nohaile
Headquarters
Berkeley, CA
Categories
HealthTech
Life Sciences
MedTech
-
Mike Nohaile
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.